APP and Alzheimer disease: Interestingly, a hyperactive phenotype has been previously reported in two different transgenic mouse models for AD characterized by the overexpression of mutant human APP and major deposits of parenchymal amyloid plaques (Filali, Lalonde, & Rivest, 2011; Roberson et al., 2007).